lactic acid has been researched along with ono 1301 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, M; Hirata, Y; Igarashi, T; Sakai, Y; Sata, M; Soeki, T | 1 |
| Haraguchi, T; Hazekawa, M; Morisaki, T; Sakai, Y; Uchida, T; Yoshida, M | 1 |
| Haraguchi, T; Hazekawa, M; Sakai, Y; Uchida, T; Yoshida, M | 2 |
| Hazekawa, M; Morisaki, T; Sakai, Y; Uchida, T; Yoshida, M | 1 |
| Daimon, T; Fukushima, S; Kawaguchi, N; Matsuura, N; Miyagawa, S; Nakatani, S; Okita, Y; Saito, A; Sakai, Y; Sawa, Y; Shiozaki, M; Shirasaka, T | 1 |
| Hazekawa, M; Morihata, K; Sakai, Y; Uchida, T; Yoshida, M | 1 |
| Daimon, T; Fukushima, S; Kuratani, T; Miyagawa, S; Sawa, Y; Shirakawa, Y; Watanabe, Y | 1 |
8 other study(ies) available for lactic acid and ono 1301
| Article | Year |
|---|---|
Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
Topics: Animals; Cardiomyopathy, Dilated; Cricetinae; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Enzyme Inhibitors; Fibrosis; Lactic Acid; Male; Myocardium; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Thromboxane-A Synthase; Ventricular Dysfunction, Left | 2009 |
Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
Topics: Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Carriers; Female; Injections, Intramuscular; Injections, Subcutaneous; Lactic Acid; Microspheres; Molecular Weight; Neural Conduction; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Rats; Rats, Sprague-Dawley; Reaction Time | 2011 |
Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion.
Topics: Animals; Biocompatible Materials; Epoprostenol; Infarction, Middle Cerebral Artery; Injections, Subcutaneous; Lactic Acid; Male; Microspheres; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Statistics as Topic; Thromboxane-A Synthase; Time Factors | 2012 |
The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Epoprostenol; Hippocampus; Lactic Acid; Male; Memory Disorders; Memory, Short-Term; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Rats; Rats, Wistar; Time Factors; Treatment Outcome | 2012 |
Effect of antioxidants on the stability of ONO-1301, a novel long-acting prostacyclin agonist, loaded in PLGA microspheres.
Topics: Animals; Antioxidants; Chromatography, Liquid; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostaglandins I; Pyridines | 2013 |
A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
Topics: Animals; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Cardiovascular Agents; Cell Line; Chemistry, Pharmaceutical; Cytokines; Delayed-Action Preparations; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Echocardiography, Doppler; Fibroblasts; Heart Failure; Humans; Injections, Intramuscular; Lactic Acid; Microscopy, Electron; Mitochondria, Heart; Myocardium; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Recovery of Function; RNA, Messenger; Stroke Volume; Time Factors; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2013 |
The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
Topics: Administration, Topical; Angiogenesis Inducing Agents; Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Liberation; Epoprostenol; Lactic Acid; Male; Mice; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Rats | 2014 |
Development of a prostacyclin-agonist-eluting aortic stent graft enhancing biological attachment to the aortic wall.
Topics: Adhesiveness; Animals; Aorta, Thoracic; Biomarkers; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cell Movement; Cells, Cultured; Chemistry, Pharmaceutical; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Drug-Eluting Stents; Endoleak; Endothelial Cells; Feasibility Studies; Fibroblasts; Foreign-Body Migration; Humans; Lactic Acid; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Polyesters; Polymers; Prostaglandins I; Pyridines; Time Factors | 2014 |